MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Pulmonary Rehabilitation Before Lung Cancer Resection

Not Applicable

Completed

Conditions: Chronic Obstructive Lung Disease
Lung Cancer
COPD
Emphysema

Interventions: Other: Usual Care
Behavioral: Mindfulness Based Pulmonary Rehabilitation

First Posted Date: 2012-09-11

Last Posted Date: 2020-01-07

Lead Sponsor: Mayo Clinic

Target Recruit Count: 27

Registration Number: NCT01682850

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States

and more 1 locations

Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer

Phase 2

Terminated

Conditions: Cancer
Depression
Anxiety

Interventions: Drug: Placebo
Drug: Ketamine

First Posted Date: 2012-09-07

Last Posted Date: 2016-02-29

Lead Sponsor: Mayo Clinic

Target Recruit Count: 5

Registration Number: NCT01680172

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Yuma Regional Medical Center, Yuma, Arizona, United States

MRS Probe Study of Alcohol

Not Applicable

Completed

Conditions: Heavy Dose Drinkers

First Posted Date: 2012-09-06

Last Posted Date: 2014-06-30

Lead Sponsor: Mayo Clinic

Target Recruit Count: 40

Registration Number: NCT01679444

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function

Phase 1

Completed

Conditions: Cardiorenal Syndrome (CRS)

Interventions: Drug: Placebo
Drug: Candesartan

First Posted Date: 2012-09-05

Last Posted Date: 2021-11-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 33

Registration Number: NCT01678794

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

SCD Use to Prevent Deep Venous Thrombosis (DVT) in Patients With PICC Lines

Not Applicable

Terminated

Conditions: Deep Vein Thrombosis

Interventions: Device: Pneumatic SCD - VenaFlow System (DJO Global)

First Posted Date: 2012-08-22

Last Posted Date: 2018-01-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 78

Registration Number: NCT01670188

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Pasireotide LAR in Severe Polycystic Liver Disease

Phase 2

Completed

Conditions: Somatostatin Analogs
Polycystic Liver Disease
Autosomal Dominant Polycystic Kidney Disease
Autosomal Dominant Polycystic Liver Disease

Interventions: Drug: Pasireotide LAR
Drug: Placebo

First Posted Date: 2012-08-21

Last Posted Date: 2020-05-01

Lead Sponsor: Mayo Clinic

Target Recruit Count: 48

Registration Number: NCT01670110

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness

Phase 1

Completed

Conditions: Vestibular Migraine
Chronic Subjective Dizziness

Interventions: Drug: Sertraline
Drug: Verapamil

First Posted Date: 2012-08-21

Last Posted Date: 2015-08-24

Lead Sponsor: Mayo Clinic

Target Recruit Count: 32

Registration Number: NCT01669304

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Phase 2

Withdrawn

Conditions: Blastic Phase Chronic Myelogenous Leukemia
Untreated Adult Acute Lymphoblastic Leukemia
B-cell Adult Acute Lymphoblastic Leukemia
Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia
Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Interventions: Drug: nilotinib
Biological: rituximab
Drug: cyclophosphamide
Drug: doxorubicin hydrochloride
Drug: vincristine sulfate
Drug: methotrexate
Drug: cytarabine
Drug: prednisone
Drug: mesna
Drug: dexamethasone
Drug: leucovorin calcium

First Posted Date: 2012-08-21

Last Posted Date: 2015-10-30

Lead Sponsor: Mayo Clinic

Registration Number: NCT01670084

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough

Completed

Conditions: Scleroderma Lung

First Posted Date: 2012-08-17

Last Posted Date: 2016-01-08

Lead Sponsor: Mayo Clinic

Target Recruit Count: 7

Registration Number: NCT01667042

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States

Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth

Phase 3

Completed

Conditions: Parkinson's Disease

Interventions: Drug: Rifaximin

First Posted Date: 2012-08-10

Last Posted Date: 2016-08-04

Lead Sponsor: Mayo Clinic

Target Recruit Count: 49

Registration Number: NCT01662791

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy